MRX trades 14.4% above Wall Street's consensus target of $57.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes MRX achieves its forward estimates and maintains a stable P/E multiple of 13.0x. This scenario reflects the blended consensus of 6 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Marex Group plc Ordinary Shares (MRX) has a Wall Street consensus price target of $57.50, based on estimates from 6 covering analysts. With the stock currently trading at $67.21, this represents a potential downside of -14.4%. The company has a market capitalization of $4.83B.
Analyst price targets range from a low of $55.00 to a high of $60.00, representing a 9% spread in expectations. The median target of $57.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 6 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, MRX trades at a trailing P/E of 17.4x and forward P/E of 13.0x. The forward PEG ratio of 0.32 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow -25.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $124.64, with bear and bull scenarios of $78.53 and $164.23 respectively. Model confidence stands at 52/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
VIRTVirtu Financial, Inc. | $5.4B | $63.23 | $52.00 | -17.8% | Hold | 9.9x | 13 |
MKTXMarketAxess Holdings Inc. | $4.2B | $118.60 | $169.83 | +43.2% | Hold | 14.8x | 24 |
PIPRPiper Sandler Companies | $5.3B | $75.08 | $97.58 | +30.0% | Hold | 15.9x | 11 |
LPLALPL Financial Holdings Inc. | $24.6B | $307.58 | $441.00 | +43.4% | Buy | 13.5x | 25 |
IBKRInteractive Brokers Group, Inc. | $41.9B | $94.57 | $87.67 | -7.3% | Buy | 37.4x | 19 |
GSThe Goldman Sachs Group, Inc. | $321.2B | $1042.98 | $989.70 | -5.1% | Hold | 17.4x | 55 |
MSMorgan Stanley | $350.2B | $222.04 | $201.25 | -9.4% | Buy | 18.5x | 52 |
JEFJefferies Financial Group Inc. | $10.8B | $52.81 | $62.40 | +18.2% | Hold | 14.8x | 9 |
SFStifel Financial Corp. | $11.5B | $74.97 | $93.44 | +24.6% | Buy | 11.9x | 22 |
HOODRobinhood Markets, Inc. | $101.7B | $112.90 | $112.33 | -0.5% | Buy | 60.3x | 25 |
Quick answers to the most common questions about buying MRX stock.
MRX's consensus price target is $57.5, -14.4% below the current price of $67.21. The 6 analysts tracking MRX see downside risk at present valuations.
MRX has a consensus rating of "Buy" based on 6 Wall Street analysts. The rating breakdown is predominantly bullish, with 6 Buy/Strong Buy ratings. The consensus 12-month price target of $57.5 implies -14.4% downside from current levels.
With a forward P/E of 12.9772x, MRX trades at a relatively low valuation. The consensus target of $57.5 implies -14.4% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $60 for MRX, while the most conservative target is $55. The consensus of $57.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $164 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
MRX is moderately covered, with 6 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month MRX stock forecast based on 6 Wall Street analysts shows a consensus price target of $57.5, with estimates ranging from $55 (bear case) to $60 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $125, with bear/bull scenarios of $79/$164.
Our quantitative valuation model calculates MRX's fair value at $125 (base case), with a bear case of $79 and bull case of $164. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 52/100.
MRX trades at a forward P/E ratio of 13.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 17.4x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on MRX, with 0 Sell ratings and a price target of $57.5 (-14.4% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
MRX analyst price targets range from $55 to $60, a 9% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $57.5 consensus represents the middle ground. Our model's $79-$164 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.